Vimarsana
Biggest News Aggregation in the World

Donga Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Donga Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Donga Pharmaceuticals Today - Breaking & Trending Today

New CEOs to lead SK Group's ICT units - Vimarsana News

New CEOs to lead SK Group's ICT units

Published: December 1, 2022

SK Group carried out an annual reshuffle of CEOs at its affiliates, Thursday, indicating its intention to focus more on stable operations next year amid growing uncertainties in the global business environment. Most of the group's vice chairman-level executives ― SK Inc. CEO Jang Dong-hyun, SK Innovation CEO Kim Jun and SK hynix CEO Park Jung-ho ― maintained their positions.

Source: koreatimes.co.kr
Related Topics:
Soult UkpyolsiSouth KoreaKyonggi DoUnited StatesCholla NamdoChoo Hyeong WookAhn Jae HyunCho Dae SikJeon Kwang HyunYu Jeong JoonCho Kyung MokLee Dong HoonJang Dong HyunKim JunLee Hyung HeeYoon Poong YoungDonga PharmaceuticalsSk Supex CouncilSk GroupSk IncKorea ChamberRoivant SciencesSk EnergySupex CouncilSk Telecom
ImmunoForge Inc. receives U.S. FDA ODD for PF1801 - Vimarsana News

ImmunoForge Inc. receives U.S. FDA ODD for PF1801

Published: October 28, 2021

SEOUL, South Korea and SILVER SPRING, Md., Oct. 28, 2021 /PRNewswire/ -- ImmunoForge (Co-CEOs Sung-Min Ahn, Kiho Chang), a company specializing in developing new drugs for rare musculoskeletal

Source: finanznachrichten.de
Related Topics:
Soult UkpyolsiSouth KoreaKyongsang BuktoJim BallanceImmunoforge CoKostenloser WertpapierhandelKiho ChangUs BranchDonga PharmaceuticalsLg Life SciencesSung Min AhnDuchenne Muscular DystrophyOrphan Drug DesignationMuscular DystrophyVice PresidentGachon Genetic Science Research InstituteGachon University Gil HospitalAnguk Pharmaceutical